Literature DB >> 22833183

Abnormal endothelial function in ED patients with normal nocturnal penile tumescence and rigidity: is it the role of psychogenic factors?

Y-P Huang1, Y-D Zhang, Y Gao, F-J Yao, Y Wang, X Chen, Y-L Ye, B Ouyang, S-F Chen, X-X Yuan, W Ran, Y-P Dai, X-Z Sun, C-H Deng.   

Abstract

Underlying endothelial dysfunction (EnD) may present in the early stage of ED or psychogenic ED. We retrospectively evaluated 191 ED patients with effective nocturnal penile tumescence and rigidity (NPTR) recording, including detailed medical and psychosexual history, International Index of Erectile Function-5 and vascular parameter. All patients were allocated into psychogenic and organic groups according to the NPTR test. Brachial artery flow-mediated dilation (FMD) was used to diagnose EnD, and ED patients were classified into two groups: non-EnD (FMD10) and EnD (FMD<10). General and vascular parameters were compared between psychogenic and organic groups, and non-EnD and EnD groups with ED were compared in terms of NPTR parameters. In all, 48.7% and 51.3% patients were diagnosed as psychogenic and organic ED, respectively. 73.1% of the psychogenic patients had EnD and 39.8% organic patients had normal endothelial function. In all parameters, only the FMD value showed significant difference between psychogenic and organic ED groups (8.26±2.57 vs 9.16±2.76, P=0.020). No statistical difference was founded in NPTR parameters between non-EnD and EnD groups (P>0.05). In conclusion, NPTR cannot effectively identify the underlying vasculogenic ED from psychogenic ED. Psychogenic causes may cause or aggravate EnD in these ED patients with normal NPTR.

Entities:  

Mesh:

Year:  2012        PMID: 22833183     DOI: 10.1038/ijir.2012.26

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  1 in total

1.  Human urine-derived stem cells alone or genetically-modified with FGF2 Improve type 2 diabetic erectile dysfunction in a rat model.

Authors:  Bin Ouyang; Xiangzhou Sun; Dayu Han; Shenfu Chen; Bing Yao; Yong Gao; Jun Bian; Yanping Huang; Yadong Zhang; Zi Wan; Bin Yang; Haipeng Xiao; Zhou Songyang; Guihua Liu; Yuanyuan Zhang; Chunhua Deng
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.